Simcha Therapeutics
Developer of cytokine immunotherapies intended to trigger the immune system to fight disease, particularly cancers. The company's decoy-resistant immunotherapies use directed evolution to engineer nov...
Valuation
$0
Share Price
N/A
Total Raised
$85.8M
Last Round
N/A